Labcorp Holdings Inc. (LH) Interest Coverage Ratio: 6.77x
The interest coverage ratio for Labcorp Holdings Inc. (LH) is 6.77x as of Sunday, June 14, 2026.
LH Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
6.77x
LH Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 6.77x | N/A | N/A | N/A |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 16.32x | 15.71x | 16.43x | 18.17x |
| BioNTech SE (BNTX) | $22.90B | -45.74x | 444.02x | 1201.03x | 1201.03x |
| United Therapeutics Corporation (UTHR) | $23.17B | 77.81x | 54.95x | 40.03x | 35.88x |
| Waters Corporation (WAT) | $23.17B | 17.59x | 13.40x | 13.24x | 14.07x |
| Moderna, Inc. (MRNA) | $19.80B | -307.40x | 531.75x | 531.75x | 531.75x |
| Veeva Systems Inc. (VEEV) | $25.92B | N/A | N/A | N/A | N/A |
| Hologic, Inc. (HOLX) | $16.97B | 16.73x | 11.98x | 11.81x | 13.87x |
| DexCom, Inc. (DXCM) | $29.08B | 49.83x | 40.70x | 32.97x | 24.93x |
| Biogen Inc. (BIIB) | $29.53B | 7.63x | 8.79x | 9.45x | 11.57x |
Financial Health Indicators
Interest Coverage
6.8x
Debt/Equity
0.84
Current Ratio
1.42
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Labcorp Holdings Inc. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. Interest Coverage Ratio FAQ
- What is the interest coverage ratio for Labcorp Holdings Inc. (LH)?
- The interest coverage ratio for LH stock is 6.77x.
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter